This content is from: Premium Inside Sarissa’s Healthy Returns Why the Tiger Cub and Icahn alum is outperforming other health-care funds. By Stephen Taub July 19, 2021
This content is from: Premium Glenview Closes the Year With a Stellar December The firm’s healthcare-heavy hedge fund and little-known sector fund outperformed most of their peers in 2021. By Stephen Taub January 03, 2022
This content is from: Premium Miura Global, Magnetar Launch Health-Care Funds The new offerings arrive as many established health-care fund managers find themselves in the red for the year. By Stephen Taub June 21, 2021
This content is from: Premium Health Care Funds Are Still Struggling Several life sciences hedge funds are down by double-digits this year. By Stephen Taub October 15, 2021
This content is from: Opinion Private Credit Is a Driver, Not a Drug, of the American Economy A response to attacks on private credit markets. By Drew Maloney February 12, 2020
This content is from: Premium The Hedge Funds Poised to Profit From a Drug Maker’s IPO At least four hedge funds own nearly half of the shares of the latest biopharma company planning to go public. By Steve Taub August 22, 2019
